Home » Harvard Health Blog » Contributor

Peter Zimetbaum, MD

Peter Zimetbaum, MD
Contributor

Peter Zimetbaum, MD is the Richard A. and Susan F. Smith Professor of Cardiovascular Medicine at Harvard Medical School and the Associate Chief and Director of Clinical Cardiology at the Beth Israel Deaconess Medical Center. Dr. Zimetbaum is a cardiac electrophysiologist with a particular interest in the clinical management of atrial fibrillation.

Posts by Peter Zimetbaum, MD

DOACs now recommended over warfarin to prevent blood clots in people with atrial fibrillation

Peter Zimetbaum, MD

Contributor

For decades, people with atrial fibrillation were prescribed warfarin to prevent blood clots. But a new type of anticoagulant medication (known as DOACs) that came on the market in 2010 has proven to be at least as effective as warfarin, with fewer side effects and without the need for blood test monitoring.

Read more »